AA

Archana Anupam Gond

Director Director DIN 07161133
DIN 07161133 First appointment May 2015 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since May 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Archana Anupam Gond

Data last updated:

Archana Anupam Gond has 11 years in corporate governance. Formerly with 1 company, such as Caius Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07161133
Primary Designation Director
First Appointment 18 May 2015
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Caius Pharmaceutical Private Limited U74999MH2015PTC264594
Director18 May 20152015₹2.1 Lakh (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Caius Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Archana Anupam Gond

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Archana Anupam Gond

Archana Anupam Gond has 11 years in corporate governance. Formerly with 1 company, such as Caius Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

Archana Anupam Gond has expertise in General Business.

Archana Anupam Gond has 11 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available